Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Alzheimer Dementia (AD) Clinical Trial

Official title:
Interventional, Randomised, Double-blind, Study to Evaluate the Safety and Tolerability of Once Daily Versus Twice Daily Memantine Treatment in Patients With Dementia of Alzheimer's Type and MMSE Range 5 - 18

Status Completed

Clinical Trial Summary

Evaluation of the safety and tolerability of a 20 mg once daily dose of memantine compared with 10 mg given twice daily in patients with dementia of Alzheimer's type and MMSE range 5-18.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02553928
Study type	Interventional
Source	H. Lundbeck A/S
Contact
Status	Completed
Phase	Phase 4
Start date	October 2015
Completion date	July 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05911932` - Investigating Genetic Status in Patients Presenting to Clinic
Active, not recruiting	`NCT03672201` - Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia	N/A
Not yet recruiting	`NCT06330155` - A Genetic Study for Alzheimer Dementia: Case-control Study
Completed	`NCT04113967` - Efficacy of a Biodanza Program in People With Alzheimer's Disease.	N/A
Completed	`NCT03221296` - Fall Prevention - Vestibular Rehabilitation	N/A
Completed	`NCT03070821` - Therapy of Alzheimer's Disease With Neurofeedback	N/A